Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Usana Health Sciences (USNA) Return on Capital Employed (2016 - 2026)

Usana Health Sciences has reported Return on Capital Employed over the past 16 years, most recently at 5.71% for Q2 2026.

  • Quarterly Return on Capital Employed fell 368.0% to 5.71% in Q2 2026 from the year-ago period, while the trailing twelve-month figure was 5.71% through Apr 2026, down 368.0% year-over-year, with the annual reading at 6.07% for FY2026, 597.0% down from the prior year.
  • Return on Capital Employed was 5.71% for Q2 2026 at Usana Health Sciences, down from 6.17% in the prior quarter.
  • Over five years, Return on Capital Employed peaked at 44.29% in Q1 2022 and troughed at 5.71% in Q2 2026.
  • The 5-year median for Return on Capital Employed is 18.11% (2024), against an average of 19.57%.
  • Year-over-year, Return on Capital Employed surged 519bps in 2022 and then tumbled -2011bps in 2023.
  • A 5-year view of Return on Capital Employed shows it stood at 24.88% in 2022, then dropped by -25bps to 18.68% in 2023, then plummeted by -38bps to 11.63% in 2024, then tumbled by -41bps to 6.84% in 2025, then fell by -16bps to 5.71% in 2026.
  • Per Business Quant, the three most recent readings for USNA's Return on Capital Employed are 5.71% (Q2 2026), 6.17% (Q1 2026), and 6.84% (Q3 2025).